Yahoo
NasdaqGM - Nasdaq Real Time Price USD

CorMedix Inc. (CRMD)

5.32 +0.09 (+1.72%)
At close: November 6 at 4:00:01 PM EST
5.35 +0.03 (+0.56%)
After hours: November 6 at 7:54:28 PM EST
Trade CRMD on Coinbase

News headlines

Updated 31m ago
Powered by Yahoo Scout

CorMedix is approaching its November 12, 2026 third-quarter report with a mixed setup. Management reaffirmed 2026 revenue guidance of $325 million to $345 million, while reimbursement uncertainty for DefenCath remains the central investor concern. The FDA’s Priority Review for a REZZAYO expansion provides a separate potential catalyst in the first quarter of 2027.

Mobilize your Website
View Site in Mobile | Classic
Share by: